Related Experiment Video
Updated: May 21, 2026

ROS Live Cell Imaging During Neuronal Development
Published on: February 9, 2021
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
Sebastian Altenhöfer1, Pamela W M Kleikers, Kim A Radermacher
1Department of Pharmacology, Cardiovascular Research Institute Maastricht, Vascular Drug Discovery Group, Faculty of Medicine, Health and Life Science, Maastricht University, The Netherlands.
Abstract:
Reactive oxygen species (ROS) are cellular signals but also disease triggers; their relative excess (oxidative stress) or shortage (reductive stress) compared to reducing equivalents are potentially deleterious. This may explain why antioxidants fail to combat diseases that correlate with oxidative stress. Instead, targeting of disease-relevant enzymatic ROS sources that leaves physiological ROS signaling unaffected may be more beneficial. NADPH oxidases are the only known enzyme family with the sole function to produce ROS. Of the catalytic NADPH oxidase subunits (NOX), NOX4 is the most widely distributed isoform. We provide here a critical review of the currently available experimental tools to assess the role of NOX and especially NOX4, i.e. knock-out mice, siRNAs, antibodies, and pharmacological inhibitors. We then focus on the characterization of the small molecule NADPH oxidase inhibitor, VAS2870, in vitro and in vivo, its specificity, selectivity, and possible mechanism of action. Finally, we discuss the validation of NOX4 as a potential therapeutic target for indications including stroke, heart failure, and fibrosis.
Insights
Reactive oxygen species (ROS) are vital signals but can cause disease. Targeting specific ROS-producing enzymes like NADPH oxidase 4 (NOX4) may offer therapeutic benefits for conditions linked to oxidative stress.
Area of Science:
- Biochemistry
- Cellular Biology
- Pharmacology
Background:
- Reactive oxygen species (ROS) play dual roles as cellular signals and disease triggers.
- Imbalances in ROS (oxidative or reductive stress) can be detrimental, explaining antioxidant therapy limitations.
- NADPH oxidases (NOX) are key enzymatic ROS producers, with NOX4 being a widely distributed isoform.
Purpose of the Study:
- To critically review experimental tools for assessing NOX and NOX4 roles.
- To characterize the NADPH oxidase inhibitor VAS2870, focusing on its specificity, selectivity, and mechanism.
- To discuss NOX4 as a therapeutic target for diseases like stroke, heart failure, and fibrosis.
Main Methods:
- Review of existing research tools: knock-out mice, siRNAs, antibodies, and inhibitors.
- In vitro and in vivo characterization of the small molecule inhibitor VAS2870.
- Assessment of NOX4's potential as a therapeutic target.
Main Results:
- Evaluation of the strengths and limitations of various NOX/NOX4 research tools.
- Detailed analysis of VAS2870's properties, including its specificity and mechanism of action.
- Identification of NOX4 as a promising target for treating oxidative stress-related diseases.
Conclusions:
- NOX4 is a critical regulator of cellular redox balance.
- Targeting specific NOX enzymes, like NOX4, offers a promising therapeutic strategy.
- VAS2870 shows potential as a tool for NOX4 research and therapy development.
Related Concept Videos
Redox Reactions
Redox Reactions
Role of Reduced Coenzymes NADH and FADH₂
Peroxisomes
Peroxisomes
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within peroxisomes...

